StemStrength™ Deluxe Now Available on

SomaCeuticals, an AngioSoma Inc. subsidiary, leverages online retail giant for new deluxe formula of its flagship product.

HOUSTON–AngioSoma (OTC: SOAN), a leading biotechnology research and development company, announces today the availability of the anticipated new and improved version of its popular StemStrength™ formula on  The new StemStrength™ is available for both Women and Men, plus it will come in an AM and PM formulation. The new product will be offered through AngioSoma’s retail brand, SomaCeuticals (

StemStrength™ is a natural nutraceutical, delivered in capsule form, engineered to provide energy, focus, accelerated fat loss, and more rapid muscle gain, among many other benefits.  Designed to be taken in the morning and before bed for maximum effect, StemStrength™ represents a complete solution for Women and Men looking for an edge in their workouts or daily life.   The timing of supplementation is important since the body needs different nutrients in the morning than in the evening. The morning formula excels at creating energy, focus and power for the day’s work ahead. The evening formula maximizes your recovery and helps you enjoy a restful sleep.

The new StemStrength™ is now available for purchase in the company’s ecommerce store, or “Our partnership with Amazon allows us to bring our new formulation to market in a wider audience.” said Alex Blankenship, President. “This move is just the beginning of our progress towards our goal of market saturation for our innovative new product.”

AngioSoma continues to innovate for its customers across a wide spectrum of health-related products. This new enhanced formula of StemStrength™ allows the company to reach a wider audience as it prepares consumer sales channels for this product and others coming down the development pipeline.

View products on  Go to Amazon Now

Our products can also be found on our ecommerce site:


AngioSoma, Inc. (, a Nevada corporation based in Houston, Texas, is dedicated to improving the mental and physical wellbeing of men and women. To accomplish that purpose, we are launching a line of supplements under our SomaCeuticals™ common identity. Our supplements cover three industry segments: nutraceuticals, cosmeceuticals, and pharmaceuticals.


Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words “believes,” “expects,” “anticipate” or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the company to differ materially from those expressed or implied by such forward-looking statements.


AngioSoma, Inc.
Alex Blankenship